PRESS RELEASE published on 09/13/2023 at 15:00, 2 years 8 months ago Eckert & Ziegler collaborates with RefleXion Medical and Telix Pharmaceuticals to Expand Treatment Options for Prostate Cancer Patients
PRESS RELEASE published on 08/10/2023 at 07:45, 2 years 9 months ago Eckert & Ziegler Continues Positive Sales Development in the First Half of 2023
PRESS RELEASE published on 07/21/2023 at 15:21, 2 years 10 months ago EQS-Adhoc: Eckert & Ziegler again achieves sales growth compared to the previous year and confirms its forecast for 2023. Decline in earnings compared to same period last year due to extraordinary items.
PRESS RELEASE published on 06/08/2023 at 11:31, 2 years 11 months ago Eckert & Ziegler: PentixaPharm Receives BfArM-Clearance for its Therapeutic to conduct a Clinical Trial in Lymphoma
PRESS RELEASE published on 06/07/2023 at 17:18, 2 years 11 months ago ckert & Ziegler: Annual General Meeting Approves Dividend of EUR 0.50 per Share. Reorganization of the Executive Board, Supervisory Board and Group Executive Committee.
PRESS RELEASE published on 05/30/2023 at 13:00, 2 years 11 months ago Eckert & Ziegler to Host First Radionuclide Theranostics Forum in Boston, MA
PRESS RELEASE published on 05/15/2023 at 09:27, 3 years ago Reorganization in the Executive Board of Eckert & Ziegler
PRESS RELEASE published on 05/11/2023 at 07:45, 3 years ago Eckert & Ziegler with Strong Sales Growth in the First Quarter of 2023
PRESS RELEASE published on 05/08/2023 at 11:15, 3 years ago Eckert & Ziegler: Recognized Australian Endocrine & Hypertension Center Joins International Groups with a Clinical Trial of PentixaPharm’s Primary Aldosteronism Lead Candidate
PRESS RELEASE published on 04/25/2023 at 17:59, 3 years 1 month ago EQS-Adhoc: Eckert & Ziegler Publishes Preliminary Figures for Q1/2023 with Double-digit Sales Growth, Earnings Decline and Confirmation of 2023 Full-Year Guidance
Published on 05/27/2026 at 23:42, 24 minutes ago New Horizon Aircraft Ltd. Announces Closing of $25 Million Offering of Common Shares
Published on 05/27/2026 at 23:05, 1 hour 1 minute ago Vox Royalty Announces Annual and Special Meeting Results
Published on 05/27/2026 at 23:05, 1 hour 1 minute ago Avino Reports Voting Results of Its 2026 Annual General Meeting
Published on 05/27/2026 at 23:00, 1 hour 6 minutes ago Collingwood Adopts Semi-Annual Financial Reporting Framework
Published on 05/27/2026 at 23:00, 1 hour 6 minutes ago Green Bridge Metals Reports Initial Assays from Drill Program
Published on 05/27/2026 at 23:29, 36 minutes ago Market entry in Brazil: DEUTZ expands its energy business in Latin America
Published on 05/27/2026 at 23:09, 56 minutes ago EQS-Adhoc: DEUTZ AG acquires Brazilian generator manufacturer Maxi Trust Power Ltda.
Published on 05/27/2026 at 20:52, 3 hours 13 minutes ago EQS-Adhoc: REPLOID Group AG: Procedural deficiencies related to the appointment of auditors in prior periods require remediation. Publication of the 2025 Annual Statements delayed.
Published on 05/27/2026 at 20:32, 3 hours 34 minutes ago Sirma Group Holding AD reports strong profitability growth in Q1 2026
Published on 05/27/2026 at 19:55, 4 hours 11 minutes ago IGEL Brings Now & Next Workspace & Endpoint Security Summits to Five European Cities
Published on 05/27/2026 at 23:00, 1 hour 6 minutes ago BIOPHYTIS CHANGES ITS FINANCING AGREEMENT WITH HEXAGON CAPITAL FUND TO ENSURE ITS €2 MILLION FACILITY IS RENEWABLE
Published on 05/27/2026 at 20:28, 3 hours 37 minutes ago Combined Shareholders’ Meeting of May 27, 2026
Published on 05/27/2026 at 17:45, 6 hours 21 minutes ago Imerys-05-2026-information-share-capital-and-voting-rights-as-of-30-April-2026
Published on 05/27/2026 at 17:45, 6 hours 21 minutes ago Description of Share buyback program - May 2026
Published on 05/27/2026 at 17:45, 6 hours 21 minutes ago Report on share repurchases from 20 to 26 May 2026
